Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $315 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare (NYSE:HCA) and maintained a price target of $315.
September 14, 2023 | 3:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on HCA Healthcare and maintained a price target of $315.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for HCA Healthcare. The maintained price target of $315 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100